C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/04 (2006.01) A61K 31/4725 (2006.01) A61P 17/00 (2006.01) A61P 37/00 (2006.01) C07D 217/06 (2006.01) C07D 217/16 (2006.01) C07D 217/22 (2006.01) C07D 413/14 (2006.01)
Patent
CA 2710067
The present application discloses oxadiazote based compounds of Formula (I) active on sphingosine-1-phosphate (S1P) in particular useful to treat lupus erythematosus. A is phenyl or a 5 or 6-membered heleroaryl ring; B is selected from one of the following; Formulae: (a) (b) (c)
La présente invention décrit des composés à base d'oxadiazole de formule (I) actifs sur la sphingosine-1-phosphate (S1P), en particulier utiles pour traiter le lupus érythémateux. A est un groupe phényle ou un cycle hétéroaryle à 5 ou 6 chaînons; B est choisi parmi : Formules : (a) (b) (c)
Heer Jag Paul
Heightman Thomas Daniel
Glaxo Group Ltd.
Gowling Lafleur Henderson Llp
LandOfFree
Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxadiazole derivatives active on sphingosine-1-phosphate (s1p), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2034687